financetom
Business
financetom
/
Business
/
Medicenna Presenting Preclinical Data from its Anti-PD1-IL-2 BiSKIT and IL-2 Super Agonist Programs
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Medicenna Presenting Preclinical Data from its Anti-PD1-IL-2 BiSKIT and IL-2 Super Agonist Programs
Nov 8, 2024 11:14 PM

10:51 AM EST, 11/08/2024 (MT Newswires) -- Medicenna Therapeutics ( MDNAF ) on Friday said new preclinical data from its BiSKIT (MDNA113) and IL-2 super agonist (MDNA11) programs will be presented today at the 39th Annual Meeting of Society for Immunotherapy of Cancer, being held in Houston, Texas. In addition, updated clinical results from the MDNA11 Phase 1/2 ABILITY-1 study will be presented Saturday Nov. 9, 2024 at the meet.

Price: 2.28, Change: -0.19, Percent Change: -7.69

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
NowVertical Up 12% After Announcing Debt-to-Equity Conversions That Provide Cash Savings
NowVertical Up 12% After Announcing Debt-to-Equity Conversions That Provide Cash Savings
Jan 2, 2025
02:08 PM EST, 01/02/2025 (MT Newswires) -- NowVertical Group ( NOWVF ) on Thursday entered into a debt settlement agreement with the vendors or former owners of Acrotrend Solutions, which include NowVertical's ( NOWVF ) Chief Executive Officer Sandeep Mendiratta, and that provide the global data and analytics company with cash savings going forward. According to a statement, the vendors...
--Tesla Cybertruck Added to List of EVs Eligible for US Subsidy, Bloomberg Reports
--Tesla Cybertruck Added to List of EVs Eligible for US Subsidy, Bloomberg Reports
Jan 2, 2025
02:02 PM EST, 01/02/2025 (MT Newswires) -- Price: 378.90, Change: -24.94, Percent Change: -6.18 ...
Lilly asks to join lawsuit over compounded versions of its weight-loss drugs
Lilly asks to join lawsuit over compounded versions of its weight-loss drugs
Jan 2, 2025
* Lilly seeks to protect interests in compounded drug case * FDA affirms no shortage of tirzepatide drugs * Compounded versions cheaper, often not covered by insurers By Brendan Pierson Jan 2 (Reuters) - Eli Lilly ( LLY ) has asked to join in opposing a lawsuit brought by compounding pharmacies against the U.S. Food and Drug Administration over the...
Market Chatter: Tesla Cybertruck Added to List of EVs Eligible for US Subsidy
Market Chatter: Tesla Cybertruck Added to List of EVs Eligible for US Subsidy
Jan 2, 2025
02:07 PM EST, 01/02/2025 (MT Newswires) -- Tesla's (TSLA) Cybertruck joined the short list of electric vehicles that qualify for up to $7,500 in US tax credits, Bloomberg reported Thursday, citing the Department of Energy and Environmental Protection Agency. Currently, 18 EV and plug-in hybrids qualify for a credit, down from 22 last year, the report said. Tesla didn't immediately...
Copyright 2023-2025 - www.financetom.com All Rights Reserved